CompilationStudy shows effectiveness of adjuvanted vaccine RSVPreF3 OA respiratory syncytial virus (RSV) in people over 60 years of age and…
Last Thursday, the autonomous communities decided to stop implementing a project of measures to prevent and control respiratory diseases, which…
Compilationmodern announced that the European Commission (EC) has granted marketing authorization to mRESVIA (mRNA-1345), its mRNA vaccine against respiratory syncytial…
Juan Leon GarciaContinuous and ongoing vaccination from the beginning of life until the last stage of life will allow you…